19 completed, 3 terminated, 1 recruiting, 1 unknown. 25 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 25 | Completed 19, Terminated 3, Recruiting 1, Unknown 1, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow Kidney Disease: new trials by email Literature Review of Kidney Disease trials Research Report on Kidney Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy Mezagitamab, Placebo - Kidney Disease | Phase 3 | Recruiting | Takeda | 347 | 2025-07-15 | 2026-11-04 |
| Designing a Bayesian Model of the Plasma Clearance of Calcium Edetate de Sodium for the Calculation of GFR and Validity Compared to the Renal Clearance of Inulin Dosage of Calcium edetate de sodium - Kidney Disease | Phase 3 | Completed | University Hospital, Limoges | 30 | 2014-12-01 | 2019-01-11 |
| SystemCHANGE: An Intervention for Medication Change in Adult Kidney Transplant Patients SystemCHANGE, Patient-education attention control - Kidney Disease | Phase 3 | Unknown | Cynthia Russell | 84 | 2014-06-01 | 2018-05-04 |
| Prevention of Serious Adverse Events Following Angiography IV isotonic saline, IV isotonic bicarbonate, N-acetylcysteine - Acute Renal Failure, Kidney Disease | Phase 3 | Completed | VA Office of Research and Development | 5177 | 2013-10-07 | 2025-11-05 |
| Pediatric Chronic Kidney Disease Safety and Efficacy cinacalcet capsule, placebo, Standard of Care - Chronic Kidney Disease, Hyperparathyroidism | Phase 3 | Terminated | Amgen | 43 | 2011-06-28 | 2020-06-29 |
| Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients Cinacalcet, Placebo - Chronic Allograft Nephropathy, Chronic Kidney Disease | Phase 3 | Completed | Amgen | 114 | 2009-12-03 | 2018-10-17 |
| Remote Ischemic Preconditioning In Abdominal Organ Transplantation RIPC by Inflation of Pneumatic Tourniquet - Kidney Disease, Liver Disease | Phase 3 | Completed | University of Medicine and Dentistry of New Jersey | 85 | 2009-04-01 | 2015-01-14 |
| Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney Disease Darbepoetin Alfa, Placebo - Anemia, Chronic Kidney Disease | Phase 3 | Terminated | Amgen | 116 | 2008-09-16 | 2022-11-29 |
| VA NEPHRON-D: Diabetes iN Nephropathy Study losartan, lisinopril - Kidney Disease, Nephropathy | Phase 3 | Terminated | US Department of Veterans Affairs | 1448 | 2008-07-01 | 2015-05-29 |
| 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney Disease ABT-335 plus rosuvastatin, Rosuvastatin - Dyslipidemia, Kidney Disease | Phase 3 | Completed | AstraZeneca | 280 | 2008-06-01 | 2012-10-03 |
| Safety Evaluation of Use Sodic Enoxaparin Enoxaparin sodic - Kidney Disease | Phase 3 | Completed | Azidus Brasil | 60 | 2008-01-01 | 2008-05-07 |
| Treatment for Subjects With Chronic Kidney Disease Receiving Haemodialysis Aranesp® - Kidney Disease | Phase 3 | Completed | Amgen | 200 | 2005-05-01 | 2008-05-05 |
| Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease Darbepoetin Alfa - Anemia, Kidney Disease | Phase 3 | Completed | Amgen | 446 | 2005-03-01 | 2008-02-28 |
| Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis Darbepoetin Alfa - Kidney Disease, Chronic Kidney Disease | Phase 3 | Completed | Amgen | 110 | 2004-10-01 | 2009-05-22 |
| Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis Cinacalcet HCl - Kidney Disease, Chronic Kidney Disease | Phase 3 | Completed | Amgen | 400 | 2004-10-01 | 2013-05-08 |
| Olmesartan Medoxomil in Diabetes Mellitus Olmesartan medoxomil, Placebo Tablets - Diabetes Mellitus, Type 2, Cardiovascular Disease | Phase 3 | Completed | Sankyo Pharma Gmbh | 4449 | 2004-10-01 | 2010-01-20 |
| Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease darbepoetin alfa SF - Kidney Disease, Chronic Kidney Disease | Phase 3 | Completed | Amgen | 1100 | 2004-10-01 | 2013-05-24 |
| Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT) Placebo, darbepoetin alfa - Kidney Disease, Diabetes Mellitus | Phase 3 | Completed | Amgen | 4038 | 2004-08-01 | 2022-11-08 |
| Zemplar® Capsule in Reducing Serum Intact Parathyroid Hormone Levels in Chronic Kidney Disease Stage 5 Subjects on Hemodialysis or Peritoneal Dialysis Zemplar Capsule - Kidney Disease | Phase 3 | Completed | Abbott | 78 | 2004-08-01 | 2011-01-19 |
| Study for Subjects With Chronic Kidney Disease(CKD) Not Receiving Dialysis De Novo Administration of Darbepoetin Alfa - Chronic Kidney Disease, Kidney Disease | Phase 3 | Completed | Amgen | 100 | 2004-05-01 | 2009-07-10 |
Showing 20 of 25. Sign in to see all of them.
Kidney Diseases (25) · Renal Insufficiency, Chronic (13) · Anemia (9) · Acute Kidney Injury (2) · Diabetes Mellitus, Type 2 (2) · Hyperparathyroidism (2) · Kidney Failure, Chronic (2) · Cardiovascular Diseases (1) · Coronary Artery Disease (1) · Delayed Graft Function (1) · Diabetes Mellitus (1) · Diabetic Nephropathies (1) · Dyslipidemias (1) · Glomerulonephritis (1) · HIV Infections (1)
Female Urogenital Diseases (25) · Female Urogenital Diseases and Pregnancy Complications (25) · Male Urogenital Diseases (25) · Urogenital Diseases (25) · Urologic Diseases (25) · Pathological Conditions, Signs and Symptoms (15) · Pathologic Processes (14) · Renal Insufficiency (14) · Chronic Disease (13) · Disease Attributes (13) · Hematologic Diseases (9) · Hemic and Lymphatic Diseases (9) · Endocrine System Diseases (6) · Metabolic Diseases (5) · Nutritional and Metabolic Diseases (5)
Darbepoetin alfa (7) · Cinacalcet (3) · 2-(4-(4-chlorobenzoyl)phenoxy)-2-methylpropanoic acid (1) · Acetylcysteine (1) · Irbesartan (1) · Lisinopril (1) · Losartan (1) · Olmesartan Medoxomil (1) · Rosuvastatin Calcium (1) · Sirolimus (1) · Sodium Chloride (1) · Spironolactone (1) · Standard of Care (1) · Valsartan (1) · fenofibric acid (1)
Amgen (12) · Abbott (1) · AstraZeneca (1) · Azidus Brasil (1) · Cynthia Russell (1) · Melbourne Health (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Sankyo Pharma Gmbh (1) · Takeda (1) · US Department of Veterans Affairs (1) · University Hospital, Limoges (1) · University of Medicine and Dentistry of New Jersey (1) · VA Office of Research and Development (1) · Wyeth is now a wholly owned subsidiary of Pfizer (1)
United States (11) · Australia (5) · Germany (4) · Poland (4) · Belgium (3) · France (3) · Puerto Rico (3) · Spain (3) · Austria (2) · Canada (2) · Hungary (2) · Italy (2) · Malaysia (2) · Mexico (2) · Russia (2)
Baburao Koneru, M.D. (1) · Gavin G Becker, MBBS MD (1) · Laura A Williams, M.D., MPH (1) · Linda Fried, MD MPH (1) · Lynda Anne Szczech, MD, MSCE (1) · Prof. Hermann Haller, MD (1) · Steven D. Weisbord, MD MSc (1)
PMID 36791280, PMID 17116009, PMID 17295668, PMID 17329707, PMID 18675764, PMID 19110359, PMID 19210145, PMID 19501439, PMID 19876613, PMID 19954265, PMID 21150933, PMID 21388309, PMID 22104547, PMID 22418908, PMID 23891363, PMID 24206457, PMID 24552328, PMID 24772521, PMID 25014549, PMID 25157242, PMID 25452859, PMID 26299230, PMID 27421884, PMID 29035939, PMID 29130810, PMID 30445841, PMID 31291507, PMID 33107592, PMID 36094829, PMID 36975019, PMID 37651553, PMID 38018702, PMID 38682786, PMID 40465397, PMID 40548378
2025 (1)